Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketotifen for STEMI (multicenter randomized placebo-controlled Phase 4 study)
ChiCTR2500114700Phase 4Not yet recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in myocardial infarction (MI) comparing Ketotifen group with Placebo control group (2 arms). Primary endpoint: Major adverse cardiovascular events. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
ketotifen
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR2500114700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114700.